BiotechTube
Home/Genelux/Thomas Zindrick, J.D., M.B.A.
TZ

Thomas Zindrick, J.D., M.B.A.

Chairman of the Board, President & Chief Executive Officer

Genelux

Therapeutic Areas

Oncology

Genelux Pipeline

DrugIndicationPhase
Olvi-Vec (olvimulogene nanivacirepvec)Platinum-Resistant/Refractory Ovarian CancerPhase 2/3
Olvi-VecSmall Cell Lung Cancer (SCLC)Phase 2
GLX-401Undisclosed Solid TumorsPreclinical

Leadership Team at Genelux

JL
James L. Tyree
Former Chief Financial Officer
DP
Dr. Paul Fischer, M.D.
Former Chief Medical Officer
DA
Dr. Aladar A. Szalay, Ph.D.
Founder and Chief Scientific Officer
View full Genelux profile